Decreased severity of collagen antibody and lipopolysaccharide-induced arthritis in human IL-32β overexpressed transgenic mice
暂无分享,去创建一个
D. Yoon | J. Hong | Dong Hun Lee | Sukgil Song | M. Park | Dae Hwan Kim | S. Han | Youngsoo Kim | Hee-Pom Lee | J. Ban
[1] E. Riley,et al. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..
[2] D. Yoon,et al. Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals , 2013, Cell Death and Disease.
[3] L. Joosten,et al. Novel insights into the biology of interleukin-32 , 2013, Cellular and Molecular Life Sciences.
[4] Mingli Xiang,et al. SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage , 2013, PloS one.
[5] C. Akdis,et al. Inhibition of angiogenesis by IL-32: possible role in asthma. , 2012, The Journal of allergy and clinical immunology.
[6] J. Zachary,et al. Localized Production of IL-10 Suppresses Early Inflammatory Cell Infiltration and Subsequent Development of IFN-γ–Mediated Lyme Arthritis , 2012, The Journal of Immunology.
[7] H. J. Kim,et al. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals , 2011, Oncogene.
[8] L. Joosten,et al. Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritis , 2011, Proceedings of the National Academy of Sciences.
[9] L. Joosten,et al. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade , 2010, Annals of the rheumatic diseases.
[10] C. Dinarello,et al. Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitis , 2010, Proceedings of the National Academy of Sciences.
[11] Hua Huang,et al. IL-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated THP-1 Human Macrophages , 2010, The Journal of Immunology.
[12] Y. Shyr,et al. Interleukin-32β Propagates Vascular Inflammation and Exacerbates Sepsis in a Mouse Model , 2010, PloS one.
[13] D. Yoon,et al. A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10 , 2009, Immunology.
[14] D. Yoon,et al. Identification of the most active interleukin‐32 isoform , 2009, Immunology.
[15] G. Mabilleau,et al. Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation , 2009, PloS one.
[16] P. Allavena,et al. Cancer related inflammation: the macrophage connection. , 2008, Cancer letters.
[17] D. Yoon,et al. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. , 2008, Journal of immunological methods.
[18] Wan-Wan Lin,et al. A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.
[19] Y. Kochi,et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases , 2006, Arthritis research & therapy.
[20] C. Dinarello,et al. IL-32, a novel cytokine with a possible role in disease , 2006, Annals of the rheumatic diseases.
[21] L. Joosten,et al. Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism , 2006, PLoS medicine.
[22] Do-Young Yoon,et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Ohno,et al. Involvement of IL-32 in activation-induced cell death in T cells. , 2006, International immunology.
[24] P. Tak,et al. Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA , 2001, Annals of the rheumatic diseases.
[25] G. Burmester,et al. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences]. , 2001, Zeitschrift fur Rheumatologie.
[26] O. Meyer. [Role of anti-TNF therapy in rheumatoid arthritis]. , 2000, Presse medicale.
[27] Huiling He,et al. Identification of a novel gene expressed in activated natural killer cells and T cells. , 1992, Journal of immunology.
[28] I. Hunneyball,et al. Antigen-induced arthritis in mice. , 1986, British journal of clinical practice. Supplement.
[29] M. Ehrenstein,et al. Cells of the synovium in rheumatoid arthritis B cells , 2007 .
[30] A. Takayanagi,et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. , 2007, Clinical and experimental immunology.
[31] D. Yoon,et al. Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.
[32] M. Mayo,et al. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.